Vertex Pharmaceuticals (NASDAQ:VRTX)

Top Analyst Upgrades and Downgrades: Albermarle, Amgen, Applied Materials, Biogen, CRISPR, CrowdStrike, CSX, Kroger, Slack, Teva, Xerox and More

Stocks were mixed in the premarket on Tuesday and the day was just looking for direction after last week's all-time highs. Investors still have a lot of pressing issues and ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Dropbox, EA, Halliburton, Intuit, Juniper Networks, ProLogis, Silicon Motion, Taiwan Semi, Textron, Vertex and More

Stocks were indicated to have a mixed opening bell on Tuesday, but the S&P 500 was last seen back above 3,000 and is now well within 1% of an all-time ...
Read Full Story »

How Biotech and Big Pharma Have Upside Heading Into Earnings

Biotech and many of the so-called Big Pharma have been duds in 2019. Despite many FDA approvals and some powerful mergers and royalty deals, the political pressure around drug pricing ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Agilent, Alphabet, Altria, Amazon, Boeing, Caterpillar, Chipotle, E*Trade, Gap, Snap, Twitter and More

Stocks were indicated to open marginally higher on Friday as earnings season is so far proving to be not as bad as many investors had modeled in for the third ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Abbott Labs, CSX, IBM, Netflix, Occidental, Whiting, Amgen, Gilead, Merck, Pfizer and More

Stocks were indicated to open marginally higher on Thursday as the world appears to have better hopes for a Brexit framework out of Europe. Investors are having to grapple with ...
Read Full Story »

Jefferies Has 4 Red-Hot Growth Stocks to Buy With Huge Upside Potential

More and more, the companies that we cover on Wall Street are starting to agree that while the future's still reasonably bright for the U.S. economy, it may be one ...
Read Full Story »

Vertex Scores Key Analyst Upgrade on Top of Making an Acquisition

Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) has seen a lot of choppy trading in 2019, rising from about $164 at the start of the year to near $195 during the first ...
Read Full Story »

Vertex Pharmaceuticals and Other Biotech Stocks With Recent Golden Crosses

Golden crosses and death crosses are common signals in technical analysis and refer to the relationship between short-term and long-term moving averages. The golden cross typically is seen as a ...
Read Full Story »

Citigroup Sees Big Upside for 2 of the Largest Biotechs

After quite some time of muted or negative performance, big biotech may be worth a look again. Citigroup analyst Mohit Bansal assumed coverage of the large-cap biotech space and sees ...
Read Full Story »

Tuesday’s Top Analyst Upgrades and Downgrades: Tesla, Uber, Amgen, Biogen, Gilead, Deckers, Vertex Pharma, KKR and More

Although the broad markets have been in a slump recently amid China trade talks, the S&P 500 and Dow futures for Tuesday morning were relatively positive. While there has been ...
Read Full Story »

What CRISPR Has Planned for Transfusion-Dependent Beta Thalassemia

When CRISPR Therapeutics A.G. (NASDAQ: CRSP) announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for CTX001 for the treatment of transfusion-dependent beta thalassemia, its ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Alcoa, Apple, Autodesk, BB&T, Bed Bath & Beyond, Camping World, Nvidia, Vertex, Voya and More

Stocks were indicated to open higher on Tuesday as bond yields appear to be stabilizing after the yield curve inverted late last week. Investors need to consider how they want ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Boeing, Booking, Camping World, Domino’s, iRobot, MetLife, Neogen, Southern Copper, Vertex, Worldpay and More

Stocks were indicated to open higher on Tuesday morning after Monday's gains. With the market having recovered so much in 2019, investors have to be considering how they want their ...
Read Full Story »

Major Biopharma Catalysts Coming in the First Quarter of 2019

Biotech and pharmaceutical companies generally are involved in the lengthy process of getting their drug candidates to market through clinical trials. The amount of risk involved ranges from fair to ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Aflac, Akamai, BioMarin, Caesars Entertainment, CBS, Crocs, GW Pharma, Medtronic, Netflix, Sirius XM and More

Stocks entered the new year on a sour note, with equity futures down about 1.5% after weaker Chinese economic data. While investors used to buy every sell-off, the volatility in ...
Read Full Story »